Pharma Supplier Hub

TransCure bioServices is a humanized mouse model CRO providing CD34+ human immune system, humanized liver, double-humanized and conventional mouse platforms for oncology, inflammation, infectious disease and liver research. With over a decade of experience, AAALAC accreditation and 70 staff, they design and run flexible, transparent preclinical studies focused on efficacy, immunotoxicity and hepatotoxicity in highly predictive in vivo models.

Hybrigenics Services is a biotechnology partner specializing in Y2H-based protein interaction discovery, drug–target identification and synthetic nanobody selection. Using platforms such as ULTImate Y2H™, YChemH, Y2HChem and Hybribody, the company supports fundamental, pharmaceutical and plant research with fee‑for‑service R&D solutions for protein interaction mapping, molecular glues/PROTACs characterization and custom VHH nanobody development.

GelTech Labs is a San Diego–based startup that automates hydrogel and biomaterials testing with its Carousel instrument, R&D services, and AnGel AI platform. It focuses on high-throughput, reproducible characterization and formulation with 21 CFR Part 11–compliant workflows for pharma, wound care, and broader biomaterials applications.

Hydrosome Labs is a Chicago-area biotechnology company specializing in patented ultrafine bubble (Hydrosome H2O) technology to enhance water’s performance as a delivery medium. Its chemical-free, hydrodynamic cavitation process improves nutrient and gas transfer, cellular uptake, hydration, and bioprocess efficiency across precision fermentation, biomanufacturing, beverages, cosmetics and controlled environment agriculture.

IBM is a global technology and consulting company that supports healthcare and life sciences organizations with AI, data, hybrid cloud and automation solutions. It offers specialized consulting and platforms that help pharmaceutical clients modernize core systems, enable data-driven R&D and operations, and explore accelerated discovery using advanced computing.

IDBS is a Danaher company providing cloud-based scientific informatics and laboratory data management solutions for biopharma and other science-driven organizations. Its platforms support digital workflows, data readiness for AI/ML, and compliant operations across the drug development lifecycle, backed by ISO, SOC and ESG certifications and recognition as a platinum pharma supplier.

Integrated DNA Technologies (IDT) is a Danaher-owned genomics solutions provider specializing in custom DNA/RNA oligos, CRISPR tools, NGS library prep and capture, gene fragments, qPCR assays, and GMP nucleic acid manufacturing. Headquartered in Coralville, Iowa, IDT supports global pharma, biotech, and diagnostics customers with rapid turnaround, extensive modification options, and OEM and assay development services.

Impact Laboratories Limited (trading as Impact Solutions) is a UKAS-accredited ISO 17025 testing laboratory based in Livingston, Scotland. Founded in 2002, the company provides pharmaceutical and medical packaging testing, 95kPa pressure differential testing, UN dangerous goods certification, and materials analysis for regulated industries.

INDICAL BIOSCIENCE is a Leipzig‑based veterinary diagnostics company providing complete molecular and immunological testing workflows for livestock, poultry and companion animals. Its portfolio spans automated nucleic acid extraction (IndiMag), pathogen‑specific qPCR and ELISA assays, and AI‑powered fecal analyzers (OvaCyte), supported by global distribution and specialist technical support.

INmune Bio Inc. is a NASDAQ-listed, clinical-stage biotech developing innate immune system therapies for Alzheimer’s disease and cancer. Its pipeline includes XPro1595 for neuroinflammation in early Alzheimer’s and INKmune/INB03 for oncology, guided by a biomarker-driven, patient-centric clinical development strategy.

IKA England Ltd is the UK subsidiary of IKA, supplying laboratory and process technology from Oxford to pharma, biotech and other R&D-intensive industries. Through the global IKA platform, it offers lab instruments, process systems, battery and bioprocessing solutions that support workflows from bench-scale research to industrial manufacturing.

Illumina is a global genomics leader providing next‑generation sequencing platforms, microarrays, library prep kits, and bioinformatics software for research, translational, and clinical applications. Headquartered in San Diego, the company supports oncology, infectious disease, reproductive health, and population genomics with scalable technologies, training, and 24/7 support, making it a key partner for pharma and diagnostics buyers.

Serimmune Inc. is an immune intelligence company providing advanced immune profiling and antibody testing solutions based on its SERA platform. Using peptide display libraries, sequencing, and machine learning, Serimmune supports biomarker discovery, multiplex diagnostics, infectious disease panels, and population serosurveillance from small-volume serum samples.

ImmuneOncia Therapeutics is a Korean immuno-oncology biopharmaceutical company developing PD-L1 and CD47 antibody drugs and a dual CD47/PD-L1 candidate for cancer treatment. With headquarters in Yongin and an R&D center in Seoul, it aims to deliver Korea’s first immune-oncology drug through optimized targeting, rapid preclinical development, and differentiated clinical strategies.

Immunexpress Inc. is a privately held molecular diagnostics company founded in 2006, headquartered in Seattle with offices in Brisbane. The company develops SeptiCyte® host-response diagnostic tests, including SeptiCyte® RAPID, an FDA-cleared, CE-marked, and TGA-cleared PCR-based assay that differentiates sepsis from non-infectious inflammation in approximately one hour.

Immuto Scientific is a Madison, Wisconsin–based private biotech and CRO focused on structural surfaceomics for oncology and other diseases. Using native-state structural proteomics, ultrasensitive mass spectrometry, and AI/ML, it discovers disease-specific surface protein conformations and epitopes to enable first-in-class precision therapeutics and offers related analytical services to drug developers.

Impact Laboratories is the independent verifier for My Green Lab® Certification, delivering third‑party verification and impact measurement for sustainable laboratories and laboratory products. As the commercial subsidiary of non-profit My Green Lab, it combines certification content, enterprise-scale software tools, and verified data to help bioscience and pharmaceutical labs credibly demonstrate environmental performance and align with international sustainability best practices.

Toxys is a Dutch biotech CRO providing innovative in vitro toxicology assays such as ToxTracker®, ReproTracker® and ToxProfiler™ for mechanistic, animal-free safety assessment. Operating from state-of-the-art labs in Leiden with additional presence in the US, Toxys supports pharma, chemical, cosmetics and food companies with early hazard identification and mode-of-action data.

InDevR is a vaccine-focused analytical technology company providing microarray-based platforms, multiplexed assays, and custom services that accelerate vaccine and biotherapeutic development and QC. Its VaxArray Platform, seasonal influenza kits, and expert assay development capabilities support rapid, standardized testing for mRNA, polysaccharide, conjugate, and viral vector vaccines across R&D and GMP environments. InDevR is now part of SSI Diagnostica Group.

Infinant Health is a life-science supplier focused on infant gut microbiome health, especially B. infantis–based products and research. Its public site highlights Evivo with MCT Oil, B. infantis EVC001, and INF108 as part of a neonatal and pediatric health strategy.

Infinite Health Collaborative (i‑Health) is a physician‑owned network of independent local medical practices offering coordinated multispecialty outpatient care across cardiology, endocrinology, family medicine, ophthalmology, orthopedics, pediatrics, plastic surgery, vascular & interventional radiology, and women’s health. It focuses on patient‑first, value‑based care, shared services like pelvic health therapy and centralized billing, while preserving physician autonomy and patient choice.

Ingenza is a UK-based CRDMO serving pharma and biotech with biologics, small molecule, and sustainable biotech solutions. Its proprietary inGenius® platform covers gene optimization, strain and cell-line engineering, protein production, fermentation, bioprocessing, and biocatalysis.

Inlabtec AG is a Swiss lab-equipment company specializing in automated serial dilution systems for microbiology labs. Its Serial Diluters and Serial Dilution Bags replace traditional glass tubes to deliver faster, standardized, ISO-compatible workflows with reduced labor, cost and waste for food, pharma and other microbiology-intensive industries.

InnoSIGN was a precision medicine company that commercialized the OncoSIGNal™ mRNA-based pathway activity profiling platform to interpret gene expression and multi-omics data for drug discovery, diagnostics, and treatment selection. It offered cloud-based analysis and test solutions to quantify signal transduction pathway activity in cancer and immune cells before ceasing operations, with its website now maintained as an archive.